Search
Legend Biotech Corp
LEGNAdd to Watchlist
18.550USD
-0.500-2.62%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.59BMarket Cap
LossP/E TTM
More Details of Legend Biotech Corp Company
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Legend Biotech Corp Info
Ticker SymbolLEGN
Company nameLegend Biotech Corp
IPO dateJun 04, 2020
CEOHuang (Ying)
Number of employees2600
Security typeDepository Receipt
Fiscal year-endJun 04
Address2101 Cottontail Lane
CitySOMERSET
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code08873
Phone17328505598
Websitehttps://investors.legendbiotech.com/
Ticker SymbolLEGN
IPO dateJun 04, 2020
CEOHuang (Ying)
Company Executives of Legend Biotech Corp
Name
Name/Position
Position
Shareholding
Change
Dr. Ying Huang, Ph.D.
Dr. Ying Huang, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
98.23K
-9.11%
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
12.90K
+40.88%
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Dr. Corazon Dating (Corsee) Sanders, Ph.D.
Dr. Corazon Dating (Corsee) Sanders, Ph.D.
Independent Director
Independent Director
--
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Mr. Wai Man (Philip) Yau, CPA
Mr. Wai Man (Philip) Yau, CPA
Independent Director
Independent Director
--
--
Dr. Fangliang (Frank) Zhang, Ph.D.
Dr. Fangliang (Frank) Zhang, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Ms. Ye (Sally) Wang
Ms. Ye (Sally) Wang
Director
Director
--
-100.00%
Dr. Patrick Casey, Ph.D.
Dr. Patrick Casey, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tomas J. (Tom) Heyman, Jr.
Mr. Tomas J. (Tom) Heyman, Jr.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Ying Huang, Ph.D.
Dr. Ying Huang, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
98.23K
-9.11%
Dr. Li Mao
Dr. Li Mao
Independent Director
Independent Director
12.90K
+40.88%
Dr. Li Zhu, Ph.D.
Dr. Li Zhu, Ph.D.
Director
Director
4.20K
--
Dr. Corazon Dating (Corsee) Sanders, Ph.D.
Dr. Corazon Dating (Corsee) Sanders, Ph.D.
Independent Director
Independent Director
--
--
Mr. Xiaohui (Darren) Ji
Mr. Xiaohui (Darren) Ji
Independent Director
Independent Director
--
--
Mr. Wai Man (Philip) Yau, CPA
Mr. Wai Man (Philip) Yau, CPA
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Legend Biotech Corp?
The top five shareholders of Legend Biotech Corp are: Dr. Ying Huang, Ph.D.
How many institutions hold shares of Legend Biotech Corp (LEGN)?
As of 2026Q1, 554 institutions hold shares of Legend Biotech Corp, with a combined market value of approximately 93.85M, accounting for 50.74% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -15564003.00.